2833703-74-3
Chemical Structure
FGFR3-IN-10
- CAS No.: 2833703-74-3
- Formula:C23H22ClFN8O2
- Molecular Weight:496.92
IUPAC Name: (S)-4-(4-(3-chloro-4-(1-(5-fluoropyridin-2-yl)-2-hydroxyethoxy)pyrazolo[1,5-a]pyridin-6-yl)-5-methyl-1H-1,2,3-triazol-1-yl)piperidine-1-carbonitrile
InChIKey: OYUCEQFRNJABJW-OAQYLSRUSA-N
SMILES: OC[C@H](C1=CC=C(C=N1)F)OC2=CC(C3=C(N(C4CCN(CC4)C#N)N=N3)C)=CN5C2=C(Cl)C=N5
Biological Activity: FGFR3-IN-10 is a selective FGFR3 inhibitor that inhibits FGFR3 kinase activity. FGFR3-IN-10 can be used in research related to cancer, systemic sclerosis, fibrosis, pulmonary fibrosis, achondroplasia, lethal dwarfism, severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), and Muenke syndrome[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
FGFR3-IN-10 | FGFR3-IN-10 is a selective FGFR3 inhibitor that inhibits FGFR3 kinase activity. FGFR3-IN-10 can be used in research related to cancer, systemic sclerosis, fibrosis, pulmonary fibrosis, achondroplasia, lethal dwarfism, severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), and Muenke syndrome. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
